BCL9

gene product
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
133 antibodies from 20 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
36 antibodies
NovoPro Bioscience Inc.
3 antibodies
Atlas Antibodies
1 antibody
GeneTex
1 antibody
Novus Biologicals
5 antibodies
Biorbyt
10 antibodies
Abgent
1 antibody
LifeSpan BioSciences, Inc.
28 antibodies
Invitrogen Antibodies
4 antibodies
Abnova Corporation
3 antibodies
R&D Systems
2 antibodies
Proteintech Group
1 antibody
Creative Biolabs
4 antibodies
Cell Signaling Technology, Inc
1 antibody
RayBiotech, Inc.
1 antibody
United States Biological
27 antibodies
MyBioSource
2 antibodies
Creative Diagnostics
1 antibody
Sigma-Aldrich
1 antibody
GenWay
1 antibody